DCVC
The AI-enabled company works with pharma companies and research institutions on research and development for new medications.
The company received a De Novo clearance for its software in February, and is now looking to scale up its collaborations and product availability.
The in-person and virtual primary care provider has tripled its staff over the last few months.
Brookfield Growth Partners led the round, with participation from DCVC, Builders VC, Bullpen Capital, Javelin Venture Partners and Two Sigma Ventures.